NCT02965118View on ClinicalTrials.gov

CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Atopic Dermatitis
Interventions
DRUG

PAC-14028 cream 1.0%

topical application

DRUG

PAC-14028 cream Vehicle

topical application

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02965118 - CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis | Biotech Hunter | Biotech Hunter